INFLUENCE OF COMPONENTS OF METABOLIC SYNDROME ON THE COURSE OF PSORIATIC ARTHRITIS

被引：0
|
作者：
Salohiddinov, Maruf [1 ]
机构：
[1] Tashkent Med Acad, Rheumatol & Osteopathy, Tashkent, Uzbekistan
来源：
RHEUMATOLOGY | 2017年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
067
引用
收藏
页码：74 / 74
页数：1
相关论文
共 50 条
  • [21] Psoriatic arthritis and psoriasis severity as metabolic syndrome and insulin resistance predictors
    Levakov, Olivera
    Gajinov, Zorica
    Gajic, Branislava
    Vujanovic, Ljuba
    Ivkov-Simic, Milana
    Golusin, Zoran
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2022, 150 (7-8) : 456 - 461
  • [22] Metabolic syndrome in psoriatic arthritis patients: A cross-sectional study
    Sharma, Aman
    Gopalakrishnan, Dharmesh
    Kumar, Ramesh
    Vijayvergiya, Rajesh
    Dogra, Sunil
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2013, 16 (06) : 667 - 673
  • [23] Metabolic Syndrome in Patients with Psoriatic Arthritis Is Associated to Peripheral Disease Activity
    De Gaspari, Camilla
    Moraes, Julio C. B.
    Sampaio-Barros, Percival D.
    Goncalves, Celio R.
    Saad, Carla G. S.
    Goldenstein-Schainberg, Claudia
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [24] PREVALENCE OF THE METABOLIC SYNDROME ACCORDING TO VARIOUS DEFINITIONS IN PATIENTS WITH PSORIATIC ARTHRITIS
    Papagoras, C.
    Markatseli, T. E.
    Milionis, H. J.
    Kaltsonoudis, E.
    Voulgari, P. V.
    Drosos, A. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 1049 - 1049
  • [25] Tildrakizumab Efficacy and Safety in Patients with Psoriatic Arthritis by Metabolic Syndrome Status
    Kavanaugh, Arthur
    Raychaudhuri, Siba
    Ritchlin, Christopher
    Asahina, Akihiko
    Rahman, Proton
    Murphy, Fred
    Rozzo, Stephen
    Yao, Siu-Long
    Chou, Richard C.
    Husni, Elaine
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3795 - 3797
  • [26] Increased Prevalence of Metabolic Syndrome and Adipocytokine Levels in a Psoriatic Arthritis Cohort
    Feld, Joy
    Nissan, Sarit
    Eder, Lihi
    Rahat, Michal Amit
    Elias, Muna
    Rimar, Doron
    Laor, Arie
    Bitterman, Haim
    Zisman, Devy
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 (06) : 302 - 307
  • [27] PREVALENCE AND DIFFERENCES OF THE METABOLIC SYNDROME IN PATIENTS WITH PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS
    Nemes, D.
    Amaricai, E.
    Catan, L.
    Dragoi, M.
    Popa, D.
    Puenea, G.
    Andrei, D.
    Balacescu, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 951 - 951
  • [28] Effects of tumor necrosis factor-α blockade on metabolic syndrome components in psoriasis and psoriatic arthritis and additional lessons learned from rheumatoid arthritis
    Channual, Jennifer
    Wu, Jashin J.
    Dann, Frank J.
    DERMATOLOGIC THERAPY, 2009, 22 (01) : 61 - 73
  • [29] Impact of 24-month treatment with etanercept, adalimumab, or methotrexate on metabolic syndrome components in a cohort of 210 psoriatic arthritis patients
    Luisa Costa
    Francesco Caso
    Mariangela Atteno
    Antonio Del Puente
    Md Abud Darda
    Paolo Caso
    Augusta Ortolan
    Ugo Fiocco
    Roberta Ramonda
    Leonardo Punzi
    Raffaele Scarpa
    Clinical Rheumatology, 2014, 33 : 833 - 839
  • [30] Impact of 24-month treatment with etanercept, adalimumab, or methotrexate on metabolic syndrome components in a cohort of 210 psoriatic arthritis patients
    Costa, Luisa
    Caso, Francesco
    Atteno, Mariangela
    Del Puente, Antonio
    Darda, Md Abud
    Caso, Paolo
    Ortolan, Augusta
    Fiocco, Ugo
    Ramonda, Roberta
    Punzi, Leonardo
    Scarpa, Raffaele
    CLINICAL RHEUMATOLOGY, 2014, 33 (06) : 833 - 839
12345